ANECORTAVE ACETATE (200 MG)F0E2980.997MG/MG(AI)
| Title | Journal |
|---|---|
| VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid. | Bioorganic & medicinal chemistry 20130415 |
| A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs. | Molecular vision 20120101 |
| Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors. | Clinical ophthalmology (Auckland, N.Z.) 20120101 |
| Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase. | Disease models & mechanisms 20110901 |
| Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors. | Clinical ophthalmology (Auckland, N.Z.) 20110101 |
| Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors. | Clinical ophthalmology (Auckland, N.Z.) 20110101 |
| Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits. | Molecular vision 20110101 |
| Retinoblastoma: Recent trends A mini review based on published literature. | Oman journal of ophthalmology 20110101 |
| Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate. | Investigative ophthalmology & visual science 20100601 |
| Time-lapse imaging of retinal angiogenesis reveals decreased development and progression of neovascular sprouting by anecortave desacetate. | Investigative ophthalmology & visual science 20100501 |
| In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401 |
| Suppression of corticosteroid-induced ocular hypertension in sheep by anecortave. | Archives of ophthalmology (Chicago, Ill. : 1960) 20100301 |
| Suppression and reduction of corticosteroid-induced ocular hypertension by anecortave in sheep. | Archives of ophthalmology (Chicago, Ill. : 1960) 20100301 |
| Increased hypoxia following vessel targeting in a murine model of retinoblastoma. | Investigative ophthalmology & visual science 20091201 |
| Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma. | Archives of ophthalmology (Chicago, Ill. : 1960) 20090201 |
| Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation. | American journal of ophthalmology 20090101 |
| [Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches]. | Klinische Monatsblatter fur Augenheilkunde 20080601 |
| [Screening of anti-tumor parts from the seeds of Livistona chinensis and its anti-angiogenesis effect]. | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20080501 |
| Anecortave acetate for fibrotic lesions with presence of residual peripheral activity in age-related macular degeneration. | Annals of ophthalmology (Skokie, Ill.) 20080101 |
| Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth. | Molecular vision 20080101 |
| Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model. | Investigative ophthalmology & visual science 20071201 |
| An update of treatment options for neovascular age-related macular degeneration. | Hong Kong medical journal = Xianggang yi xue za zhi 20071201 |
| Diagnostic and therapeutic challenges. | Retina (Philadelphia, Pa.) 20071001 |
| [Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration]. | Klinische Monatsblatter fur Augenheilkunde 20070701 |
| Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model. | Investigative ophthalmology & visual science 20070601 |
| First clinical experience with anecortave acetate (Retaane). | Klinische Monatsblatter fur Augenheilkunde 20070401 |
| Anecortave may help choroidal neovascularization regression in serpiginous choroiditis. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20070201 |
| Progressive visual loss in subfoveal exudation in age-related macular degeneration: a meta-analysis using Lineweaver-Burke plots. | American journal of ophthalmology 20070101 |
| Mechanism of action of the angiostatic cortisene anecortave acetate. | Survey of ophthalmology 20070101 |
| Preclinical efficacy of anecortave acetate. | Survey of ophthalmology 20070101 |
| Pharmacokinetics and metabolism of anecortave acetate in animals and humans. | Survey of ophthalmology 20070101 |
| Posterior juxtascleral depot administration of anecortave acetate. | Survey of ophthalmology 20070101 |
| Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degeneration. | Survey of ophthalmology 20070101 |
| Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes. | Survey of ophthalmology 20070101 |
| The Digital Angiography Reading Center (DARC) role in the anecortave acetate clinical trials. | Survey of ophthalmology 20070101 |
| [Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies]. | Postepy higieny i medycyny doswiadczalnej (Online) 20070101 |
| Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20070101 |
| Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. | The Cochrane database of systematic reviews 20070101 |
| Treatment of choroidal neovascularization in AMD. | Ophthalmology 20061201 |
| Evolving European guidance on the medical management of neovascular age related macular degeneration. | The British journal of ophthalmology 20060901 |
| Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study. | Retina (Philadelphia, Pa.) 20060901 |
| Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study. | Retina (Philadelphia, Pa.) 20060901 |
| Anecortave acetate in the treatment of age-related macular degeneration. | Clinical interventions in aging 20060901 |
| Macular degeneration. Advances in treatment. | Mayo Clinic health letter (English ed.) 20060701 |
| Treatment of nonexudative (dry) age-related macular degeneration. | Current opinion in ophthalmology 20060601 |
| Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice. | Investigative ophthalmology & visual science 20060401 |
| [Comments on current therapeutic possibilities for neovascular age-related macula degeneration]. | Klinische Monatsblatter fur Augenheilkunde 20060401 |
| Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. | Ophthalmology 20060101 |
| The state of being noninferior. | Ophthalmology 20060101 |
| A preliminary benefit-risk assessment of verteporfin in age-related macular degeneration. | Drug safety 20060101 |
| Drug pricing for a novel treatment for wet macular degeneration: using incremental cost-effectiveness ratios to ensure societal value. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20050601 |
| Anecortave (Alcon Laboratories). | IDrugs : the investigational drugs journal 20050401 |
| Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20050101 |
| Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. | European journal of ophthalmology 20050101 |
| Ocular neovascularisation and excessive vascular permeability. | Expert opinion on biological therapy 20040901 |
| Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. | Ophthalmology 20031201 |
| [Alternative therapies for choroidal neovessels resulting from age-related macular degeneration]. | Journal francais d'ophtalmologie 20031001 |
| Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. | Retina (Philadelphia, Pa.) 20030201 |
| The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. | Investigative ophthalmology & visual science 20010101 |